Search

Author/Creator Howard, P.W.

1. ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers. (December 2016)

Authors:
Zammarchi, F.; Chivers, S.; Williams, D.G.; Adams, L.; Mellinas-Gomez, M.; Tyrer, P.; Corbett, S.; D'Hooge, F.; Dissanayake, S.; Sims, S.; Havenith, K.; Howard, P.W.; Hartley, J.A.; Van Berkel, P.H.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search